These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 12691153)
1. HIV-testing and newly-diagnosed malignant lymphomas. The SAKK 96/90 registration study. D'Addario G; Dieterle A; Torhorst J; Maibach R; Stahel R; Egli F; Lohri A; Cavalli F; Fey M; Ketterer N; Cerny T Leuk Lymphoma; 2003 Jan; 44(1):133-8. PubMed ID: 12691153 [TBL] [Abstract][Full Text] [Related]
2. Malignant lymphomas (ML) and HIV infection in Tanzania. Mwakigonja AR; Kaaya EE; Mgaya EM J Exp Clin Cancer Res; 2008 Jun; 27(1):9. PubMed ID: 18577266 [TBL] [Abstract][Full Text] [Related]
3. Hodgkin's disease in patients infected with human immunodeficiency virus: frequency, presentation and clinical outcome. Tsimberidou AM; Sarris AH; Medeiros LJ; Mesina O; Rodriguez MA; Hagemeister FB; Romaguera J; Pro B; McLaughlin P; Dang N; Cabanillas F Leuk Lymphoma; 2001 May; 41(5-6):535-44. PubMed ID: 11378571 [TBL] [Abstract][Full Text] [Related]
4. Hodgkin disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-Hodgkin lymphoma. Re A; Casari S; Cattaneo C; Facchetti F; Cadeo G; Carosi G; Rossi G Cancer; 2001 Dec; 92(11):2739-45. PubMed ID: 11753946 [TBL] [Abstract][Full Text] [Related]
5. Advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms. Franceschi S; Dal Maso L; La Vecchia C Int J Cancer; 1999 Nov; 83(4):481-5. PubMed ID: 10508483 [TBL] [Abstract][Full Text] [Related]
6. Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group. Coté TR; Biggar RJ; Rosenberg PS; Devesa SS; Percy C; Yellin FJ; Lemp G; Hardy C; Geodert JJ; Blattner WA Int J Cancer; 1997 Nov; 73(5):645-50. PubMed ID: 9398040 [TBL] [Abstract][Full Text] [Related]
7. Hodgkin's disease during HIV1 infection: the French registry experience. French Registry of HIV-associated Tumors. Andrieu JM; Roithmann S; Tourani JM; Levy R; Desablens B; le Maignan C; Gastaut JA; Brice P; Raphael M; Taillan B Ann Oncol; 1993 Sep; 4(8):635-41. PubMed ID: 8240994 [TBL] [Abstract][Full Text] [Related]
8. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003]. Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104 [TBL] [Abstract][Full Text] [Related]
9. AIDS and non AIDS-related malignant lymphoma in Tanzania. Kaaya EE; Castaños-Velez E; Ekman M; Mwakigonja A; Carneiro P; Lema L; Kitinya J; Linde A; Biberfeld P Afr Health Sci; 2006 Jun; 6(2):69-75. PubMed ID: 16916294 [TBL] [Abstract][Full Text] [Related]
10. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma. Ko YH; Kim CW; Park CS; Jang HK; Lee SS; Kim SH; Ree HJ; Lee JD; Kim SW; Huh JR Cancer; 1998 Aug; 83(4):806-12. PubMed ID: 9708949 [TBL] [Abstract][Full Text] [Related]
12. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S; J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006 [TBL] [Abstract][Full Text] [Related]
15. Malignancies in HIV-infected children at Siriraj Hospital. Sanpakit K; Veerakul G; Kriengsuntornkij W; Chokephaibulkit K; Tanphaichitr VS; Mahasandana C J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S542-8. PubMed ID: 12403230 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis C infection and risk of malignant lymphoma. Schöllkopf C; Smedby KE; Hjalgrim H; Rostgaard K; Panum I; Vinner L; Chang ET; Glimelius B; Porwit A; Sundström C; Hansen M; Adami HO; Melbye M Int J Cancer; 2008 Apr; 122(8):1885-90. PubMed ID: 18271005 [TBL] [Abstract][Full Text] [Related]
17. Cancer risk in people infected with human immunodeficiency virus in the United States. Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450 [TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-associated extranodal non-Hodgkin's lymphoma of the sinonasal tract and nasopharynx in Thailand. Mitarnun W; Suwiwat S; Pradutkanchana J Asian Pac J Cancer Prev; 2006; 7(1):91-4. PubMed ID: 16629523 [TBL] [Abstract][Full Text] [Related]
19. Changing Patterns of Lymphoma in the Antiretroviral Therapy Era in Johannesburg, South Africa. Wiggill T; Mayne E; Perner Y; Vaughan J J Acquir Immune Defic Syndr; 2021 Nov; 88(3):252-260. PubMed ID: 34354010 [TBL] [Abstract][Full Text] [Related]
20. Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma. Shepherd L; Ryom L; Law M; Hatleberg CI; de Wit S; Monforte AD; Battegay M; Phillips A; Bonnet F; Reiss P; Pradier C; Grulich A; Sabin C; Lundgren J; Mocroft A J Natl Cancer Inst; 2018 Jun; 110(6):598-607. PubMed ID: 29267895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]